دورية أكاديمية
Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
العنوان: | Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis |
---|---|
المؤلفون: | Drain, Paul K., Losina, Elena, Coleman, Sharon M., Giddy, Janet, Ross, Douglas, Katz, Jeffrey N., Bassett, Ingrid V. |
المصدر: | Drain, Paul K., Elena Losina, Sharon M. Coleman, Janet Giddy, Douglas Ross, Jeffrey N. Katz, and Ingrid V. Bassett. 2016. “Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.” BMC Pulmonary Medicine 16 (1): 147. doi:10.1186/s12890-016-0316-z. http://dx.doi.org/10.1186/s12890-016-0316-zTest. |
بيانات النشر: | BioMed Central, 2016. |
سنة النشر: | 2016 |
المجموعة: | HMS Scholarly Articles SPH Scholarly Articles |
مصطلحات موضوعية: | Tuberculosis, HIV/AIDS, Lipoarabinomannan (LAM), Urine, Diagnostic screening, South Africa |
الوصف: | Background: World Health Organization (WHO) recommends tuberculosis (TB) screening at HIV diagnosis. We evaluated the inclusion of rapid urine lipoarabinomannan (LAM) testing in TB screening algorithms. Methods: We enrolled ART-naïve adults who screened HIV-infected in KwaZulu-Natal, assessed TB-related symptoms (cough, fever, night sweats, weight loss), and obtained sputum specimens for mycobacterial culture. Trained nurses performed clinic-based urine LAM testing using a rapid assay. We used diagnostic accuracy, negative predictive value (NPV), and negative likelihood ratio, stratified by CD4 count, to evaluate screening for culture-positive TB. Results: Among 675 HIV-infected adults with median CD4 of 213/mm3 (interquartile range 85-360/mm3), 123 (18%) had culture-confirmed pulmonary TB. The WHO-recommended algorithm of any TB-related symptom had a sensitivity of 77% [95% confidence interval (CI) 69-84%] and NPV of 89% (95% CI 84-92%) for identifying active pulmonary TB. Including the LAM assay improved sensitivity (83%; 95% CI 75-89%) and NPV (91%; 95% CI 86-94%), while decreasing the negative likelihood ratio (0.45 versus 0.57). Among participants with CD4 < 100/mm3, including urine LAM testing improved the negative predictive value of symptom based screening from 83% to 87%. All screening algorithms with urine LAM performed better among participants with CD4 < 100/mm3, compared to those with CD4 ≥ 100/mm3. Conclusion: Clinic-based urine LAM screening increased the sensitivity of symptom-based screening by 6% among ART-naïve HIV-infected adults in a TB-endemic setting, thereby providing marginal benefit. |
نوع الوثيقة: | Journal Article |
اللغة: | English |
تدمد: | 1471-2466 |
العلاقة: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109839/pdfTest/; BMC Pulmonary Medicine |
DOI: | 10.1186/s12890-016-0316-z |
الوصول الحر: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:29626215Test |
حقوق: | open URL: http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAATest |
رقم الانضمام: | edshld.1.29626215 |
قاعدة البيانات: | Digital Access to Scholarship at Harvard (DASH) |
تدمد: | 14712466 |
---|---|
DOI: | 10.1186/s12890-016-0316-z |